Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?

被引:0
作者
Davood Khalili
Marjan Khayamzadeh
Karim Kohansal
Noushin Sadat Ahanchi
Mitra Hasheminia
Farzad Hadaegh
Maryam Tohidi
Fereidoun Azizi
Ali Siamak Habibi-Moeini
机构
[1] Shahid Beheshti University of Medical Sciences,Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences
[2] Shahid Beheshti University of Medical Sciences,Department of Biostatistics and Epidemiology, Research Institute for Endocrine Sciences
[3] Shahid Beheshti University of Medical Sciences,Endocrine Research Center, Research Institute for Endocrine Sciences
来源
BMC Endocrine Disorders | / 23卷
关键词
Prediabetes; Impaired glucose tolerance; Impaired fasting glucose; HOMA-IR; HOMA-B; Diabetes; Prediabetic state;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 137 条
  • [1] Yip WC(2017)Prevalence of pre-diabetes across ethnicities: a review of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) for classification of dysglycaemia Nutrients. 9 1273-98
  • [2] Sequeira IR(2018)Global aetiology and epidemiology of type 2 diabetes mellitus and its complications Nat Rev Endocrinol 14 88-236
  • [3] Plank LD(2012)The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives Nat Rev Endocrinol 8 228-233
  • [4] Poppitt SD(2014)Approaching pre-diabetes J Diabetes Complications 28 226-8
  • [5] Zheng Y(2009)Population-based incidence of type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran BMC Public Health 9 1-78
  • [6] Ley SH(2017)Pre-diabetes tsunami: incidence rates and risk factors of pre-diabetes and its different phenotypes over 9 years of follow-up Diabet Med 34 69-453
  • [7] Hu FB(2001)Subclinical states of glucose intolerance and risk of death in the US Diabetes Care 24 447-50
  • [8] Chen L(2018)Prediabetes and cardiovascular disease: pathophysiology and interventions for prevention and risk reduction Endocrinol Metab Clin 47 33-1331
  • [9] Magliano DJ(2016)Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications Exp Biol Med 241 1323-1402
  • [10] Zimmet PZ(2001)Postchallenge hyperglycemia and mortality in a national sample of US adults Diabetes Care 24 1397-116